Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies

Virchows Archiv

Volumn 450, Issue 6, 2007, Pages 665-670

  Schmid, Simone ^a   Opravil, Milos ^a   Moddel, Michael ^b   Huber, Milo ^a   Pfammatter, Rahel ^b   Keusch, Gerald ^b   Ambuhl, Patrice ^a   Wuthrich, Rudolf P ^a   Moch, Holger ^a   Varga, Zsuzsanna ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Stadtspital Waid   (Switzerland)

Author keywords

Atazanavir; HIV; Interstitial nephritis; Kidney biopsy

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; FOSCARNET; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE ATROPHY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADENINE; ADULT; ANTI-HIV AGENTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; OLIGOPEPTIDES; PHOSPHONIC ACIDS; PYRIDINES; RETROSPECTIVE STUDIES;

EID: 34250830280     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0418-3     Document Type: Article

References (25)

1. Brewster UC, Perazella MA (2004) Acute interstitial nephritis associated with atazanavir, a new protease inhibitor. Am J Kidney Dis 44:e81-e84
2. Cho ME, Kopp JB (2004) HIV and the kidney: a status report after 20 years. Curr HIV/AIDS Rep 1:109-115
3. D'Agati V, Appel GB (1998) Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18:406-421
4. D'Agati V, Jennette J, Silva F (2005) Non-neoplastic kidney diseases. ARP Press, Silver Spring, MD
5. European Medicines Agency (2006) http://www.emea.eu.int/humandocs/PDFs/ EPAR/viread/351001en8b.pdf; accessed on 8 Mar 2007
6. Fogo A, Kashgarian M (2005) Diagnostic atlas of renal pathology, 1st edn. Elsevier, Saunders
7. Friedland G, Andrews L, Schreibman T, Agarwala S, Daley L, Child M, Shi J, Wang Y, O'Mara E (2005) Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction. Aids 19:1635-1641
8. Fux C, Simcock M, Wolbers M, Bucher H, Cavassini M, Opravil M, Vernazza P, Hirschel B, Bernasconi E, Furrer H, Swiss HIV Cohort Study S (2007) Tenofovir treatment is associated with a decrease in calculated glomerular filtration rates in a large observational cohort. In: 14th Conference on retroviruses and opportunistic infections, Los Angeles, USA, 25-28 February
9. Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S, California Collaborative Treatment Group CT (2007) Increased renal impairment in patients receiving TDF+PI vs TDF+NNRTI. In: 14th Conference on retroviruses and opportunistic infections, Los Angeles, USA, 25-28 February
10. Hailemariam S, Walder M, Burger HR, Cathomas G, Mihatsch M, Binswanger U, Ambuhl PM (2001) Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy. Swiss Med Wkly 131:412-417
11. Han TM, Naicker S, Ramdial PK, Assounga AG (2006) A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69:2243-2250
12. Izzedine H, Launay-Vacher V, Peytavin G, Valantin MA, Deray G (2005) Atazanavir: a novel inhibitor of HIV-protease in haemodialysis. Nephrol Dial Transplant 20:852-853
13. Jennette JC, Olson JL, Schwartz M, Silva F (2007) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins
14. Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, Legendre C, Martinez F, Molina JM (2003) Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 36:1070-1073
15. Kern W, Laszik Z, Nadasdy T, Silva F, Bane B, Pitha J (1999) Atlas of renal pathology. Saunders, Philadelphia
16. Kim RJ, Wilson CG, Wabitsch M, Lazar MA, Steppan CM (2006) HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism. Obesity (Silver Spring) 14:994-1002
17. Moddel M, Pfammatter R, Varga Z, Keusch G (2006) Acute tubulointerstitial nephritis in HIV infection. Schweiz Rundsch Med PRAXIS 95:949-951
18. Panel on Antiretroviral Guidelines for Adult and Adolescents (2006) Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services, October 10, 2006. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentsGL.pdf. Accessed 8 Mar 2007, pp 1-113
19. Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM, Leray H, Moachon L, Vincent D, Salmon-Ceron D (2004) Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 35:269-273
20. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD (2006) HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42:1488-1495
21. Scott JD, Wolfe PR, Bolan RK, Guyer B (2006) Serious renal impairment occurs rarely with use of tenofovir DF. HIV Clin Trials 7:55-58
22. Striker G, Striker L, D'Agati V (1997) The renal biopsy, 3rd edn. Saunders
23. Szeto CC, Chow KM (2005) Nephrotoxicity related to new therapeutic compounds. Ren Fail 27:329-333
24. Valle R, Haragsim L (2006) Nephrotoxicity as a complication of antiretroviral therapy. Adv Chronic Kidney Dis 13:314-319
25. Wyatt CM, Klotman PE (2006) Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf 5:275-287